GO:0008283 | cell proliferation | 14 | 328 |
GO:0005515 | protein binding | 198 | 6024 |
GO:0050693 | LBD domain binding | 1 | 4 |
GO:0045892 | negative regulation of transcription, DNA-templated | 24 | 413 |
GO:0005737 | cytoplasm | 124 | 3767 |
GO:0070555 | response to interleukin-1 | 2 | 30 |
GO:0003682 | chromatin binding | 19 | 327 |
GO:0034341 | response to interferon-gamma | 2 | 21 |
GO:0000578 | embryonic axis specification | 1 | 7 |
GO:0005829 | cytosol | 86 | 2496 |
GO:0034097 | response to cytokine | 2 | 50 |
GO:0032868 | response to insulin | 1 | 53 |
GO:0003713 | transcription coactivator activity | 24 | 237 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 2 | 23 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1 | 3 |
GO:0006351 | transcription, DNA-templated | 57 | 1446 |
GO:0060231 | mesenchymal to epithelial transition | 1 | 7 |
GO:0030318 | melanocyte differentiation | 3 | 19 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 23 | 264 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 3 | 43 |
GO:0060711 | labyrinthine layer development | 3 | 9 |
GO:0071559 | response to transforming growth factor beta | 1 | 3 |
GO:0071104 | response to interleukin-9 | 1 | 2 |
GO:0043627 | response to estrogen | 5 | 56 |
GO:0001656 | metanephros development | 1 | 27 |
GO:0070741 | response to interleukin-6 | 1 | 3 |
GO:0042803 | protein homodimerization activity | 19 | 595 |
GO:0045893 | positive regulation of transcription, DNA-templated | 24 | 478 |
GO:0032496 | response to lipopolysaccharide | 4 | 121 |
GO:0070670 | response to interleukin-4 | 1 | 6 |
GO:0070669 | response to interleukin-2 | 1 | 3 |
GO:0060395 | SMAD protein signal transduction | 1 | 16 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 39 | 699 |
GO:0001570 | vasculogenesis | 2 | 56 |
GO:0008022 | protein C-terminus binding | 8 | 161 |
GO:0051591 | response to cAMP | 4 | 45 |
GO:0001890 | placenta development | 3 | 31 |
GO:0070410 | co-SMAD binding | 1 | 12 |
GO:0043473 | pigmentation | 1 | 20 |
GO:0044212 | transcription regulatory region DNA binding | 17 | 168 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 11 | 128 |
GO:0071105 | response to interleukin-11 | 1 | 1 |
GO:0045668 | negative regulation of osteoblast differentiation | 1 | 36 |
GO:0010628 | positive regulation of gene expression | 7 | 146 |
GO:0006915 | apoptotic process | 12 | 555 |
GO:0005634 | nucleus | 159 | 4559 |
GO:0030178 | negative regulation of Wnt signaling pathway | 4 | 35 |
GO:0043524 | negative regulation of neuron apoptotic process | 5 | 117 |
GO:0042438 | melanin biosynthetic process | 1 | 7 |
GO:0007420 | brain development | 2 | 167 |
GO:0060712 | spongiotrophoblast layer development | 1 | 7 |
GO:0071107 | response to parathyroid hormone | 1 | 3 |
GO:0006913 | nucleocytoplasmic transport | 1 | 27 |